Highlights
NASDAQ: XBIO       Xenetic Biosciences Inc
Last Price Today's Change   Day's Range   Trading Volume
2.72   -0.23 (7.80%)  2.64 - 3.09  838,200

Overview

 
Avg Volume (4 weeks):983,738
4 Weeks Range:1.69 - 3.09
4 Weeks Price Volatility (%):
73.57%
52 Weeks Range:0.44 - 5.85
52 Weeks Price Volatility (%):
42.14%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Xenetic Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on focused on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics. The company’s proprietary drug development platforms include PolyXen, which enables next-generation biologic drugs by improving their half-life and other pharmacological properties. The group’s product candidates include oncology therapeutic XBIO-101 (sodium cridanimod) for the treatment of progesterone resistant endometrial cancer (EC). The firm is based in the United States.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3395  5701  443  114 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNDL 0.714-0.029 
 BNGO 8.43+0.80 
 SENS 1.58-0.26 
 CCIV 18.36+0.55 
 CTRM 0.336-0.01 
 AMC 2.33+0.13 
 BB 9.84-0.84 
 OBSV 4.07+0.53 
 AVGR 1.47-0.37 
 ZOM 0.975-0.065